Charcot-Marie-Tooth Disease Type I Diagnosed in a 5-year-old Boy After Vincristine Neurotoxicity, Resulting in Maternal Diagnosis
Overview
Authors
Affiliations
Charcot-Marie-Tooth disease type 1, also known as hereditary motor sensory neuropathy type 1, is an uncommon autosomal dominant disease that causes destruction of peripheral nerves with a varied clinical course, but often leads to muscle weakness. If the peroneal muscle is involved, the patient may develop a characteristic slapping gait. The dose-limiting side effect of the chemotherapeutic agent vincristine is usually its neurotoxicity. We report the case of a 5-year-old patient with leukemia who developed an acute polyneuropathy after treatment with vincristine. Charcot-Marie-Tooth disease type 1 was diagnosed in the patient and, subsequently, in his mother only after vincristine toxicity was observed.
Hess P, Ventura Ferreira M, Rolles B, Kirschner M, Holtbernd F, Tometten M Clin Case Rep. 2022; 10(5):e05766.
PMID: 35540715 PMC: 9069391. DOI: 10.1002/ccr3.5766.
Kissoon T, Gururangan S, Sladky J Neurooncol Pract. 2019; 6(3):179-184.
PMID: 31385990 PMC: 6656327. DOI: 10.1093/nop/npz002.
Budure A, Winquist E, Palma D, Correa R BMJ Case Rep. 2019; 12(7).
PMID: 31308183 PMC: 6663183. DOI: 10.1136/bcr-2018-228956.
Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora E, Smith E, Donohoe C, Hertz D Am J Cancer Res. 2016; 6(11):2416-2430.
PMID: 27904761 PMC: 5126263.
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.
Beutler A, Kulkarni A, Kanwar R, Klein C, Therneau T, Qin R Ann Neurol. 2014; 76(5):727-37.
PMID: 25164601 PMC: 4388308. DOI: 10.1002/ana.24265.